AI assistant
Sending…
HEALTHEQUITY, INC. — Director's Dealing 2018
Mar 29, 2018
30722_dirs_2018-03-29_95183215-bd70-4663-a4a2-932029988f73.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEALTHEQUITY INC (HQY)
CIK: 0001428336
Period of Report: 2018-03-27
Reporting Person: Soldan Jon (Exec VP, Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-27 | Common Stock | A | 3781 | — | Acquired | 9433 | Direct |
| 2018-03-27 | Common Stock | F | 418 | $63.50 | Disposed | 9015 | Direct |
| 2018-03-28 | Common Stock | S | 995 | $61.30 | Disposed | 8020 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $28.69 | 2025-08-26 | Common Stock (50000) | 50000 | Direct |
| Stock Option (right to buy) | $24.36 | 2026-03-23 | Common Stock (12500) | 12500 | Direct |
Footnotes
F1: Each restricted stock award represents a contingent right to receive one share of the issuer's common stock. The restricted stock awards vest as to 946 shares on March 27, 2019, and in three equal installments of 945 shares on March 27, 2020, 2021 and 2022.
F2: The option becomes exercisable in two equal installments of 25,000 on August 26, 2018 and 2019.
F3: The option becomes exercisable in two equal annual installments of 6,250 shares on March 23, 2019 and 2020.
More from HEALTHEQUITY, INC.
Interim / Quarterly Report
2026
May 28
Earnings Release
2026
May 28
Annual Report
2026
May 13
Board/Management Information
2026
Apr 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Annual Report
2026
Mar 17